A progressive Indian miner and steelmaker has selected FLS to supply a full flotation technology package for what is set to ...

"A new dosing regimen to treat Bardet-Biedl Syndrome 1 (BBS1) retinal degeneration with AXV-101 (AAV9-BBS1) improves ...

Anfield acquired the Velvet-Wood mine from Uranium One in 2015. Between 1979 and 1984, Atlas Minerals mined approximately 400 ...

Careers coach and author Drew Povey, founder of Drew Povey Consultancy, spoke out after new statistics revealed 52% of Gen-Z ...

EATONTOWN, N.J., May 13, 2025 (GLOBE NEWSWIRE) -- Climb Channel Solutions (Climb), an international specialty technology ...

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, ...

Cost of License and Other Revenue: Cost of license and other revenue was $1.8 million for the three months ended March 31, ...

GEN2 is well tolerated with minimal toxicity and signs of pharmacodynamic activity in an ongoing Phase 1 dose escalation and expansion trial. GEN-1013 was studied in aggressive murine cancer models ...

Aduro Clean Technologies Inc. ("Aduro” or the "Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company ...

VYKAT XR was approved by the U.S. Food and Drug Administration (FDA) on March 26, 2025, and is now commercially available to U.S. patients. VYKAT XR is indicated for the treatment of hyperphagia in ...

The Company will host a conference call to discuss financial results for the first quarter 2025 today at 8:30 a.m. Eastern ...

Patient enrollment and randomization for the trial was initiated in early 2025 and is expected to be completed in 2026. In ...